NEUPOGEN® is a recombinant (genetically engineered) protein that stimulates the production of infection-fighting white blood cells called neutrophils that are depleted by cytotoxic chemotherapy, a condition called neutropenia.
Rare events of adult respiratory distress syndrome, splenic rupture, and sickle cell crises have been reported in postmarketing experience in patients receiving NEUPOGEN®.